APA

de Lima L. T., Vivona D., Bueno C. T., Hirata R. D. C., Hirata M. H., Luchessi A. D., de Castro F. A., de Lourdes F Chauffaille M., Zanichelli M. A., Chiattone C. S., Hungria V. T. M. & Guerra-Shinohara E. M. (20140930). Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia. : Medical oncology (Northwood, London, England).

Chicago

de Lima Luciene Terezina, Vivona Douglas, Bueno Carolina Tosin, Hirata Rosario D C, Hirata Mario H, Luchessi André D, de Castro Fabíola Attié, de Lourdes F Chauffaille Maria, Zanichelli Maria A, Chiattone Carlos S, Hungria Vania T M and Guerra-Shinohara Elvira M. 20140930. Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia. : Medical oncology (Northwood, London, England).

Harvard

de Lima L. T., Vivona D., Bueno C. T., Hirata R. D. C., Hirata M. H., Luchessi A. D., de Castro F. A., de Lourdes F Chauffaille M., Zanichelli M. A., Chiattone C. S., Hungria V. T. M. and Guerra-Shinohara E. M. (20140930). Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia. : Medical oncology (Northwood, London, England).

MLA

de Lima Luciene Terezina, Vivona Douglas, Bueno Carolina Tosin, Hirata Rosario D C, Hirata Mario H, Luchessi André D, de Castro Fabíola Attié, de Lourdes F Chauffaille Maria, Zanichelli Maria A, Chiattone Carlos S, Hungria Vania T M and Guerra-Shinohara Elvira M. Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia. : Medical oncology (Northwood, London, England). 20140930.